Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thymoma × Histocompatibility Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Pancreatic Neoplasms 4 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Melanoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thymoma 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Medulloblastoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Epilepsy 1 Ependymoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Bone Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Cyclophosphamide 4 Cisplatin 4 pembrolizumab 3 130-nm albumin-bound paclitaxel 3 selinexor 2 Thymectomy 2 Sunitinib 2 Radiotherapy 2 Pemetrexed 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Carboplatin 2 zimberelimab 1 regorafenib 1 epacadostat 1 bosutinib 1 amrubicin 1 TP protocol 1 Ramucirumab 1 Radiotherapy, Adjuvant 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation Dose Hypofractionation 1 Psychiatric Rehabilitation 1 Prednisone 1 Prednisolone 1 Patient Comfort 1 Palliative Care 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04162691 2023-01-13

Single Cell Sequencing Analysis of Thymoma

Zhejiang Cancer Hospital

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡